A Phase I, Randomised, Open, Single-Centre, Three-Period Crossover Study to Evaluate the Effect of AZD1305 on the Pharmacokinetics of Digoxin After Repeated Oral Administration of AZD1305 and Digoxin to Young Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2010
At a glance
- Drugs AZD 1305 (Primary) ; Digoxin
- Indications Arrhythmias
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 13 Jan 2009 Status changed from not yet recruiting to completed, according to the clinicaltrials.gov record.
- 30 Jul 2008 New trial record.